NCT07525323
EMG ss AMG In Robotic/Laparoscopic Surgery
Enrolling by Invitation
NAAges 18+InterventionalMayo ClinicInvestigator-initiated
~400 participants
Updated 2026-07-20 on ClinicalTrials.gov
What's tested:AMG deviceEMG
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Cumulative rocuronium dose
Measured over Perioperative/Periprocedural
Conditions
Where it's being run
1 sites across 1 statesFlorida1
Study leadership
- Johnathan Renew · PRINCIPAL_INVESTIGATOR · Mayo Clinic
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Age \> or = 18 years old
Patients willing to participate and provide an integrated, informed consent
Patients undergoing elective laparoscopic- or robotic-assisted surgical procedures
Exclusion
Patients with disorders, such as stroke, carpal tunnel syndrome, broken wrist with nerve damage, Dupuytren contracture, or any similar wrist injury.
Patients with systemic neuromuscular diseases such as myasthenia gravis.
Patients having surgery that would involve prepping the arm into the sterile field.
Patients with chronic kidney disease (eGFR \<60).
What this trial measures
- Cumulative rocuronium dosePerioperative/Periprocedural
Weight- and time-adjusted mean cumulative rocuronium dose between the AMG and EMG groups